Showing results (101-110 of 318) with videos related to

Sort By:
Pageof 32
Scientific Reports|May 12, 2019
Inhibition of tumour necrosis factor alpha in the R6/2 mouse model of Huntington's disease by etanercept treatmentJeffrey Pido-Lopez, Benedict Tanudjojo, Sahar Farag, et al.
Biological Psychiatry|February 10, 2009
Abnormal motor cortex excitability in preclinical and very early Huntington's diseaseSven Schippling, Susanne A Schneider, Khailash P Bhatia, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 16, 2009
Abnormal motor cortex plasticity in premanifest and very early manifest Huntington diseaseMichael Orth, Sven Schippling, Susanne A Schneider, et al.
Brain Communications|December 11, 2020
Longitudinal expression changes are weak correlates of disease progression in Huntington's diseaseChristopher T Mitchell, Irina Krier, Jamshid Arjomand, et al.
Annals of the New York Academy of Sciences|August 4, 2009
Saccadometry of conditional rules in presymptomatic Huntington's diseaseMatthieu P A Robert, Parashkev C Nachev, Stephen L Hicks, et al.
The Journal of Biological Chemistry|September 15, 2005
Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosisMark Kristiansen, Marcus J Messenger, Peter-Christian Klöhn, et al.
Journal of Proteome Research|March 4, 2006
Metabolic characterization of the R6/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopyTsz M Tsang, Ben Woodman, Gerard A McLoughlin, et al.
NAR Molecular Medicine|June 19, 2026
Genetic or pharmacological disruption of the MSH3 Y245/K246 IDL binding pocket slows CAG repeat expansionRob Goold, Jasmine Donaldson, Florence Gidney, et al.
The Journal of Pathology|January 5, 2024
Neural stem cell homeostasis is affected in cortical organoids carrying a mutation in AngiogeninRoss Ferguson, Michael A van Es, Leonard H van den Berg, et al.
Pageof 32